课题基金 / 基金详情

BLOCKING VIRUS SPREAD BY DCS WITH CARRAGEENAN-BASED COMPOUNDS

BLOCKING VIRUS SPREAD BY DCS WITH CARRAGEENAN-BASED COMPOUNDS
用卡拉胶基化合物阻断 DCS 传播的病毒
批准号:
7716210
负责人:
Melissa J Robbiani
金额:
$6.33万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-21 至 2009-04-30

项目摘要

项目成果

Melissa J Robbiani的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To complete our tests demonstrating that PC-817 (Carraguard plus 500 micro molar MIV-150 vs Carraguard and the placebo hydroxymethyl cellulose, HMC) is effective in preventing vaginal SHIV-RT infection of macaques, we recently challenged the final sets of animals (affording us 7 animals in each major test group for the 103 TCID50 challenge, for stronger datasets). Using recycled animals (animals uninfected from earlier challenges), we have also tested the ability of the MIV-150 alone (in HMC) for its anti-viral effects, as proof of concept that a NNRTI can act when applied vaginally. A single dose of 500 micro molar MIV-150 in HMC given 30min prior to a 104 TCID50 challenge had minimal impact on infection (2/2 infected). Whereas, applying the gel the day before, the day of, and the day after a 104 TCID50 virus challenge reduced infection. 3 of 7 animals became infected with a typical viremia, one remained uninfected, and 3 exhibited low-level infection with 2100 copies/ml peak viral loads (undetectable over time). Anti-CD8 treatment of these animals (approximately 5 months later) did not reveal a "controlled" infection (no virus spike in the plasma), suggesting that the low-level infections had been cleared. Testing the lower 103 TCID50 inoculum, we confirmed that 2 of 3 animals remained uninfected after receiving MIV-150 in HMC 30min prior to a 103 TCID50 challenge. Additional animals that received the 500 micro molar MIV-150 in HMC 30min prior to challenge with 103 TCID50 of SHIV-RT were just challenged to complete the comparisons to the Carraguard vs PC-817 treated animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel vaginal ring to prevent HIV and HSV-2 infection, as well as pregnancy
  • 批准号:
    8450072
  • 项目类别:
  • 资助金额:
    $19.42万
  • 财政年份:
    2012
  • 负责人:
    Melissa J Robbiani
  • 依托单位:
A novel vaginal ring to prevent HIV and HSV-2 infection, as well as pregnancy
  • 批准号:
    8264696
  • 项目类别:
  • 资助金额:
    $23.05万
  • 财政年份:
    2012
  • 负责人:
    Melissa J Robbiani
  • 依托单位:
HIV ENVELOPE SPECIFIC DARPIN-BASED MICROBICIDE
  • 批准号:
    8358133
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    Melissa J Robbiani
  • 依托单位:
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONS
  • 批准号:
    8358089
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    Melissa J Robbiani
  • 依托单位:
海外基金